Revenue $2.21B, up 2.2% on a year earlier. Product net sales $1.70B, up 1.8%. Software and Rentals Net Sales $511.00M, up 3.7%. Diluted EPS $0.53 against $0.51.
| Q2 FY26 | Q1 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $2.21B | $2.01B | $2.16B | +2.2% |
| Operating income | $181.00M | $81.00M | $214.00M | -15.4% |
| Net income | $92.00M | $13.00M | $90.00M | +2.2% |
| Diluted EPS | $0.53 | $0.07 | $0.51 | |
| Operating cash flow | $227.00M | -$189.00M | $169.00M | +34.3% |
| Capital expenditures | -$83.00M | -$84.00M | -$110.00M | |
| Free cash flow | $144.00M | -$273.00M | $59.00M | +144.1% |
| Q2 FY26 | Q2 FY25 | Year over year | |
|---|---|---|---|
| Product net sales | $1.70B | $1.67B | +1.8% |
| Software and Rentals Net Sales | $511.00M | $493.00M | +3.7% |
| Dental Solutions net sales | $396.00M | $338.00M | +17.2% |
| Health Information Systems net sales | $354.00M | $339.00M | +4.4% |
| MedSurg net sales | $1.37B | $1.22B | +12.6% |
| Health Information Systems Organic Sales Growth | 5.4% | 3.2% | |
| MedSurg Organic Sales Growth | 8.9% | 3.9% | |
| Organic sales growth | 9.5% | 2.8% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Solventum (SOLV) Q2 FY26 earnings: results and KPIs”, stockatlas.com/companies/SOLV/earnings/2026-q2/, data as of 3 November 2026. Links to this page are welcome.
